Page 72 - ஹைதராபாத் அடிப்படையிலானது பாரத் பயோடெக் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Vaccine, India, COVID- Edexlive

Vaccine, India, COVID- Edexlive
edexlive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from edexlive.com Daily Mail and Mail on Sunday newspapers.

United statesUnited kingdomWest bengalSri lankaAntonio guterresAnita bhatiaYale universityGeorgetown universityIndian council of medical researchUnited nationsSerum institute of indiaCalcutta universityLauding indiaDeputy executive directorVaccine maitriVaccine friendship

Covaxin demand grows among Indians after efficacy results

Covaxin demand grows among Indians after efficacy results
sentinelassam.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sentinelassam.com Daily Mail and Mail on Sunday newspapers.

Uttar pradeshMedicity gurugramAstrazeneca oxfordNarendra modiAkhil gogoiNeha guptaRahul bhargavaDepartment of clinical hematology bone marrowIndian council of medical researchSerum institute of indiaFortis memorial research instituteHyderabad based bharat biotechPrime minister narendra modiPrime ministerPune based serum instituteIndian council

Elderly people are preferring Covishield to Covaxin

Elderly people are preferring Covishield to Covaxin Many elderly people, who are receiving Covid-19 vaccines, are telling private hospitals that they prefer Covishield to Covaxin, officials of several healthcare institutes said. All hospitals in Calcutta are now administering Covishield vaccine, developed by Oxford University and AstraZeneca. The homegrown Covaxin is not supplied by the government to hospitals at this moment, said health department officials. “Most elderly people and their relatives who are coming to our hospital are asking whether we are giving Covishield or Covaxin. These vaccine recipients are telling us that if it’s Covaxin, they would come at a later date,” said Sudipta Mitra, chief executive, Peerless Hospital.

West bengalChandramouli bhattacharyaSudipta mitraAbhijit chowdhuryRn tagore international institute of cardiac sciencesNarayana healthIndian council of medical researchOxford universityInternational instituteCardiac sciencesHyderabad based bharat biotechIndian councilMedical researchமேற்கு பெங்கல்சந்திரம ou லி பட்டாச்சார்யாசூதிப்த மித்ரா

India helping to address issue of vaccine equity: Top UN Women official

Covaxin Safe, Phase 3 Results Needed To Assess Effectiveness, Says Lancet

Covaxin Safe, Phase 3 Results Needed To Assess Effectiveness, Says Lancet Covaxin Safe, Phase 3 Results Needed To Assess Effectiveness, Says Lancet Lancet has said that efficacy cannot be determined by phase 2 trials but Covaxin made by Hyderabad-based Bharat Biotech is safe/immunogenic . Made-in-India Covaxin was granted emergency approval before its final stage testing. New Delhi: Covaxin, the homegrown coronavirus vaccine that was authorized for use in January before full clinical trial data, has been declared safe, immunogenic with no serious side effects by Lancet that has published its phase 2 results. Lancet has said that efficacy cannot be determined by phase 2 trials but the vaccine made by Hyderabad-based Bharat Biotech is safe/immunogenic .

Narendra modiFaheem younusUniversity of maryland upper chesapeake healthCovaxin safeNeeded to assess effectivenessSays lancetMade in india covaxinHyderabad based bharat biotechInfectious diseasesMaryland upper chesapeake healthBharat biotechIndia covaxinPrime minister narendra modiCovaxin trialsLancet on covaxinCoronavirus vaccine